Agilent and Quest Diagnostics to Collaborate on Lung Cancer Diagnostic
The global market for cancer diagnostics & technology is expected to grow rapidly owing to the rising awareness relating to cancer and its causes, expanding support by government as far as novel activities and financing, and the expanding healthcare consumption are additionally supporting the development of this market altogether. Going ahead, the approach of non-obtrusive screening systems and new diagnostic biomarkers are anticipated to open new income streams for market players sooner rather than later. However, the nonattendance of an appropriate repayment situation and the absence of talented experts in developing economies may obstruct the market throughout the following couple of years, reports the examination.
To know
the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/1782-cancer-diagnostics-market-report
CANCER DIAGNOSTICS & TECHNOLOGY MARKET SEGMENTAL OVERVIEW
The global cancer
diagnostics & technology market is segmented based on type of
technology, application and geography.
CANCER DIAGNOSTICS & TECHNOLOGY MARKET
BY TECHNOLOGY
Based on technology, the cancer diagnostics
market is categorised into platform-based and instrument-based. Platform-based
technology consists of Polymerase Chain Reaction (PCR), In Situ Hybridization
(ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), Dna
Microarrays, Flow Cytometry. Whereas, instrument-based technology includes
imaging and biopsy. Imaging is further sub-segmented into Magentic Resonance
Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed
Tomography (PET-CT), Mammography and Ultrasound. The instrument-based segment
is expected to hold a major share of the cancer diagnostics market in 2019.
Some More...https://justpaste.it/1zlyh
CANCER DIAGNOSTICS & TECHNOLOGY MARKET
BY APPLICATION
Based on application, the global cancer
diagnostics market is segmented into lung cancer, breast cancer, colorectal
cancer, melanoma and others. Breast cancer application is relied upon to
represent a noteworthy offer of the cancer diagnostics market, by application
in 2019. Breast cancer application is anticipated to have a significant share
of the cancer diagnostics and technology market during the forecast period.
CANCER DIAGNOSTICS & TECHNOLOGY MARKET
BY GEOGRAPHY
The global cancer diagnostics &
technology market is studied across key regions like North America, Europe,
Asia Pacific, and Rest of the World. North America is anticipated to represent
the biggest market share in the cancer diagnostics market, trailed by Europe
and Asia. However, the Asian market is slated to develop at the highest CAGR in
the coming five years and fills in as an income stash for the organizations
working in the malignancy diagnostics showcase.
CANCER DIAGNOSTIC & TECHNOLOGY MARKET
KEY PLAYERS
Some of the major players operating in the
cancer diagnostics & technology market include Agilent Technologies, Inc.,
Thermo Fisher Scientific, Inc., Illumina, Inc., Becton, Dickinson and Company,
GE Healthcare, QIAGEN N.V., Abbott Laboratories, Inc., Roche Diagnostics,
Siemens Healthcare, Philips Healthcare, C.R. Bard, Inc.
Buy now Cancer Diagnostics Market Report https://www.axiommrc.com/buy_now/1782-cancer-diagnostics-market-report
Comments
Post a Comment